Apnimed拟赴美IPO融资1.6亿美元
2026-07-27 11:48:47
据彭博社报道，盐野义制药支持的晚期药物开发商Apnimed Inc.正寻求通过美国首次公开募股最多融资1.6亿美元。该公司专注于睡眠呼吸暂停药物开发。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Next article：
中国购物中心上半年客流销售双增
